Galmed Pharma (GLMD) Updates on 'At-The-Market' Financing Program; Says ~$5M Raised

September 29, 2016 9:04 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) announced that, to date, it has raised approximately $5.0 million under the Company's At-The-Market financing executed by Cantor Fitzgerald (the "ATM"). In total, to date the Company has issued 933,160 ordinary shares under the ATM at an average sale price of $5.11 per share.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Related Entities

Cantor Fitzgerald

Add Your Comment